BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15306229)

  • 1. FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo.
    Ezan J; Leroux L; Barandon L; Dufourcq P; Jaspard B; Moreau C; Allières C; Daret D; Couffinhal T; Duplàa C
    Cardiovasc Res; 2004 Sep; 63(4):731-8. PubMed ID: 15306229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FrzA gene protects cardiomyocytes from H2O2-induced oxidative stress through restraining the Wnt/Frizzled pathway.
    Tao J; Chen BD; Ma YT; Yang YN; Li XM; Ma X; Yu ZX; Liu F; Xiang Y; Chen Y
    Lipids Health Dis; 2015 Aug; 14():90. PubMed ID: 26282432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning.
    Barandon L; Dufourcq P; Costet P; Moreau C; Allières C; Daret D; Dos Santos P; Daniel Lamazière JM; Couffinhal T; Duplàa C
    Circ Res; 2005 Jun; 96(12):1299-306. PubMed ID: 15920021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FrzA, a secreted frizzled related protein, induced angiogenic response.
    Dufourcq P; Couffinhal T; Ezan J; Barandon L; Moreau C; Daret D; Duplàa C
    Circulation; 2002 Dec; 106(24):3097-103. PubMed ID: 12473558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA.
    Barandon L; Couffinhal T; Ezan J; Dufourcq P; Costet P; Alzieu P; Leroux L; Moreau C; Dare D; Duplàa C
    Circulation; 2003 Nov; 108(18):2282-9. PubMed ID: 14581414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates wnt-1 signaling.
    Dennis S; Aikawa M; Szeto W; d'Amore PA; Papkoff J
    J Cell Sci; 1999 Nov; 112 ( Pt 21)():3815-20. PubMed ID: 10523516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling.
    Goodwin AM; Sullivan KM; D'Amore PA
    Dev Dyn; 2006 Nov; 235(11):3110-20. PubMed ID: 17013885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
    Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
    J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP.
    Cong F; Schweizer L; Varmus H
    Development; 2004 Oct; 131(20):5103-15. PubMed ID: 15459103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
    Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
    J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans.
    Marchand A; Atassi F; Gaaya A; Leprince P; Le Feuvre C; Soubrier F; Lompré AM; Nadaud S
    Aging Cell; 2011 Apr; 10(2):220-32. PubMed ID: 21108734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization.
    Kim KI; Cho HJ; Hahn JY; Kim TY; Park KW; Koo BK; Shin CS; Kim CH; Oh BH; Lee MM; Park YB; Kim HS
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):91-8. PubMed ID: 16254206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
    Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
    Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit.
    Stabile E; Zhou YF; Saji M; Castagna M; Shou M; Kinnaird TD; Baffour R; Ringel MD; Epstein SE; Fuchs S
    Circ Res; 2003 Nov; 93(11):1059-65. PubMed ID: 14605018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated overexpression of a cyclin-dependent kinase inhibitor, p57Kip2, suppressed vascular smooth muscle cell proliferation.
    Takagi Y
    Hokkaido Igaku Zasshi; 2002 May; 77(3):221-30. PubMed ID: 12056049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
    Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
    Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
    Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin nuclear activation: common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation?
    Couffinhal T; Dufourcq P; Duplàa C
    Circ Res; 2006 Dec; 99(12):1287-9. PubMed ID: 17158343
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis.
    Schwencke C; Schmeisser A; Walter C; Wachter R; Pannach S; Weck B; Braun-Dullaeus RC; Kasper M; Strasser RH
    Cardiovasc Res; 2005 Oct; 68(1):128-35. PubMed ID: 15950204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.